A Study to Evaluate the Efficacy and Safety of MABT5102A in Patients With Mild to Moderate Alzheimer's Disease (ABBY)
Clinical trial NCT01343966 · COMPLETED
Trial details
- NCT number
- NCT01343966
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-04-30
- Primary completion
- 2014-02-28
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.